News

The project comes from The Get REAL Movement, a non-profit focused on fighting issues of discrimination in schools and workplaces. 

In this 10-part series, we profile doctors who are working to combat racism, change the system and improve patient care for racialized communities.

Hired for a leadership role in a new province during the pandemic, Dr. Monika Dutt was worried her long-term licence wouldn't come through before her temporary one expired.

Ponesimod is the fourth oral sphingosine 1-phosphate receptor modulator to be marketed in Canada.

Health units covering the Sudbury and Algoma regions in northern Ontario have reinstated measures including business capacity limits in light of spiking cases. Ford's Progressive Conservative government lifted those last month.